Published in J Immunol on August 28, 2009
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A (2010) 3.24
Expanding roles for CD4⁺ T cells in immunity to viruses. Nat Rev Immunol (2012) 2.94
Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol (2010) 2.76
Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge. Immunity (2010) 2.52
Antiviral instruction of bone marrow leukocytes during respiratory viral infections. Cell Host Microbe (2010) 1.89
Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol (2009) 1.72
Endogenous antigen processing drives the primary CD4(+) T cell response to influenza. Nat Med (2015) 1.45
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev (2012) 1.31
Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection. PLoS Pathog (2011) 1.28
Modeling within-host dynamics of influenza virus infection including immune responses. PLoS Comput Biol (2012) 1.26
Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells. J Virol (2012) 1.21
Hallmarks of CD4 T cell immunity against influenza. J Intern Med (2011) 1.19
Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol (2010) 1.15
Influenza virus partially counteracts restriction imposed by tetherin/BST-2. J Biol Chem (2012) 1.13
Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity. PLoS Pathog (2013) 1.12
Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Foxp3+ regulatory T cell response. J Virol (2011) 1.09
p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. J Immunol (2011) 1.08
Avian influenza rapidly induces antiviral genes in duck lung and intestine. Mol Immunol (2012) 1.05
Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J Infect Dis (2012) 1.03
Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus. Nature (2013) 1.01
Innate immune evasion strategies of influenza viruses. Future Microbiol (2010) 1.00
Animal models for influenza virus pathogenesis, transmission, and immunology. J Immunol Methods (2014) 0.98
Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections. J Virol (2012) 0.95
Dendritic cells and influenza A virus infection. Virulence (2012) 0.95
Granulocyte colony-stimulating factor protects mice during respiratory virus infections. PLoS One (2012) 0.90
NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein. Proc Natl Acad Sci U S A (2014) 0.90
The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA. J Virol (2014) 0.89
Defective viral genomes: critical danger signals of viral infections. J Virol (2014) 0.89
Systemic responses during local viral infections: type I IFNs sound the alarm. Curr Opin Immunol (2011) 0.88
Control of innate immunity by memory CD4 T cells. Adv Exp Med Biol (2011) 0.88
Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. J Virol (2013) 0.87
Estrogen mediates innate and adaptive immune alterations to influenza infection in pregnant mice. PLoS One (2012) 0.86
Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection. PLoS One (2012) 0.85
Differential effects of NS1 proteins of human pandemic H1N1/2009, avian highly pathogenic H5N1, and low pathogenic H5N2 influenza A viruses on cellular pre-mRNA polyadenylation and mRNA translation. J Biol Chem (2010) 0.84
Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor. PLoS One (2014) 0.82
Human H7N9 avian influenza virus infection: a review and pandemic risk assessment. Emerg Microbes Infect (2013) 0.82
Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency. Dis Model Mech (2013) 0.81
Impaired T cell function in argininosuccinate synthetase deficiency. J Leukoc Biol (2014) 0.80
Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I. MBio (2015) 0.78
Buying time-the immune system determinants of the incubation period to respiratory viruses. Viruses (2010) 0.78
Innate and adaptive immune responses in patients with pandemic influenza A(H1N1)pdm09. Arch Virol (2013) 0.78
Overcoming NS1-mediated immune antagonism involves both interferon-dependent and independent mechanisms. J Interferon Cytokine Res (2013) 0.77
Influenza A infection enhances antigen-induced airway inflammation and hyperresponsiveness in young but not aged mice. Clin Exp Allergy (2014) 0.76
Type I IFN signaling facilitates the development of IL-10-producing effector CD8(+) T cells during murine influenza virus infection. Eur J Immunol (2016) 0.76
Long-Lasting Impact of Neonatal Exposure to Total Body Gamma Radiation on Secondary Lymphoid Organ Structure and Function. Radiat Res (2015) 0.76
Novel avian influenza A (H7N9) virus induces impaired interferon responses in human dendritic cells. PLoS One (2014) 0.76
Early activation of MAP kinases by influenza A virus X-31 in murine macrophage cell lines. PLoS One (2014) 0.75
A corticoid-sensitive cytokine release assay for monitoring stress-mediated immune modulation. Clin Exp Immunol (2013) 0.75
The liver is a metabolic and immunologic organ: A reconsideration of metabolic decompensation due to infection in inborn errors of metabolism (IEM). Mol Genet Metab (2017) 0.75
In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med (2004) 5.07
Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog (2010) 3.89
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A (2010) 3.24
Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol (2006) 2.94
Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol (2010) 2.76
The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep (2008) 2.65
Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J Exp Med (2006) 2.53
Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein. J Exp Med (2003) 2.20
TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses. J Immunol (2004) 2.10
Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J Infect Dis (2003) 2.05
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proc Natl Acad Sci U S A (2003) 1.91
A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol (2012) 1.90
Antiviral instruction of bone marrow leukocytes during respiratory viral infections. Cell Host Microbe (2010) 1.89
MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles. J Immunol (2008) 1.68
A novel role for viral-defective interfering particles in enhancing dendritic cell maturation. J Immunol (2006) 1.51
Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol (2009) 1.50
Chromosome-specific and noisy IFNB1 transcription in individual virus-infected human primary dendritic cells. Nucleic Acids Res (2007) 1.40
Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol (2010) 1.37
Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog (2008) 1.32
Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection. PLoS Pathog (2011) 1.28
The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling. J Virol (2011) 1.26
Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J Clin Invest (2005) 1.25
Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells. J Virol (2012) 1.21
Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study. J Clin Immunol (2011) 1.16
The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells. PLoS One (2010) 1.15
The influence of pregnancy on systemic immunity. Immunol Res (2012) 1.14
Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells. Immunol Cell Biol (2011) 1.14
Cytokine-independent upregulation of MDA5 in viral infection. J Virol (2007) 1.13
Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity. PLoS Pathog (2013) 1.12
Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J Gen Virol (2005) 1.11
p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. J Immunol (2011) 1.08
A novel model of demyelinating encephalomyelitis induced by monocytes and dendritic cells. J Immunol (2006) 1.06
Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine (2009) 1.05
Sendai virus infection induces efficient adaptive immunity independently of type I interferons. J Virol (2006) 1.03
Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J Infect Dis (2012) 1.03
Characterization and distribution of colonic dendritic cells in Crohn's disease. Inflamm Bowel Dis (2004) 1.02
Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum. Obstet Gynecol (2012) 0.99
Toll-like receptor-independent triggering of dendritic cell maturation by viruses. J Virol (2006) 0.97
The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol (2009) 0.97
Estrogen inhibits dendritic cell maturation to RNA viruses. Blood (2008) 0.96
Autocrine type I IFN and contact with endothelium promote the presentation of influenza A virus by monocyte-derived APC. J Immunol (2003) 0.95
IL-11 regulates autoimmune demyelination. J Immunol (2009) 0.95
Immune response modeling of interferon beta-pretreated influenza virus-infected human dendritic cells. Biophys J (2010) 0.93
Granulocyte colony-stimulating factor protects mice during respiratory virus infections. PLoS One (2012) 0.90
Glutamate receptor subunit 3 (GluR3) immunoreactivity delineates a subpopulation of parvalbumin-containing interneurons in the rat hippocampus. J Comp Neurol (2003) 0.90
Enhanced structural stability of Concholepas hemocyanin increases its immunogenicity and maintains its non-specific immunostimulatory effects. Eur J Immunol (2012) 0.89
Highly immunostimulatory RNA derived from a Sendai virus defective viral genome. Vaccine (2013) 0.89
Systemic responses during local viral infections: type I IFNs sound the alarm. Curr Opin Immunol (2011) 0.88
Estrogen mediates innate and adaptive immune alterations to influenza infection in pregnant mice. PLoS One (2012) 0.86
Impact of alpha-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects. Clin Immunol (2009) 0.85
Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen. Reprod Biol Endocrinol (2011) 0.85
Polymorphisms in inflammatory genes are associated with term small for gestational age and preeclampsia. Am J Reprod Immunol (2014) 0.84
Immunotherapeutic effect of Concholepas hemocyanin in the murine bladder cancer model: evidence for conserved antitumor properties among hemocyanins. J Urol (2006) 0.84
Antiproliferative and uncoupling effects of delocalized, lipophilic, cationic gallic acid derivatives on cancer cell lines. Validation in vivo in singenic mice. J Med Chem (2014) 0.83
Plasma level of interferon γ induced protein 10 is a marker of sarcoidosis disease activity. Cytokine (2013) 0.82
Hemocyanin of the molluscan Concholepas concholepas exhibits an unusual heterodecameric array of subunits. J Biol Chem (2004) 0.82
High-throughput detection method for influenza virus. J Vis Exp (2012) 0.82
Different cell death mechanisms are induced by a hydrophobic flavin in human tumor cells after visible light irradiation. J Photochem Photobiol B (2011) 0.81
Mouse dendritic cell (DC) influenza virus infectivity is much lower than that for human DCs and is hemagglutinin subtype dependent. J Virol (2012) 0.81
Deficiency of melanoma differentiation-associated protein 5 results in exacerbated chronic postviral lung inflammation. Am J Respir Crit Care Med (2014) 0.81
Antiviral immunity and the role of dendritic cells. Int Rev Immunol (2002) 0.81
A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis (2008) 0.81
Immunopurification of Golgi vesicles by magnetic sorting. J Immunol Methods (2002) 0.81
[Hemocyanins as immunostimulants]. Rev Med Chil (2011) 0.79
Parvalbumin-containing interneurons in rat hippocampus have an AMPA receptor profile suggestive of vulnerability to excitotoxicity. J Chem Neuroanat (2002) 0.79
Monoclonal antibodies to molluskan hemocyanin from Concholepas concholepas demonstrate common and specific epitopes among subunits. Hybrid Hybridomics (2002) 0.79
Buying time-the immune system determinants of the incubation period to respiratory viruses. Viruses (2010) 0.78
Concholepas hemocyanin biosynthesis takes place in the hepatopancreas, with hemocytes being involved in its metabolism. Cell Tissue Res (2010) 0.77
Development of monoclonal antibodies bearing the internal image of the gizzerosine epitope and application in a competitive ELISA for fish meal. Hybrid Hybridomics (2004) 0.76
Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection. Transplantation (2005) 0.76
Correction: A specific sequence in the genome of respiratory syncytial virus regulates the generation of copy-back defective viral genomes. PLoS Pathog (2019) 0.75
A comprehensive evaluation of human plasmacytoid dendritic cells using small volumes of human blood. J Interferon Cytokine Res (2008) 0.75
Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera. medRxiv (2020) 0.75
Immune responses to viruses, bacteria, parasites and fungi in humans. Int Rev Immunol (2002) 0.75